Philippe Morlat focuses on Internal medicine, Immunology, Acquired immunodeficiency syndrome, Hepatitis C and Gastroenterology. His Internal medicine research includes themes of Surgery and Viral load. His work deals with themes such as Protease inhibitor, Cause of death and Virology, which intersect with Immunology.
He specializes in Acquired immunodeficiency syndrome, namely Sida. His Hepatitis C research incorporates themes from Hepatitis B, Hepatocellular carcinoma and Hepatitis C virus. His Gastroenterology research is multidisciplinary, incorporating elements of Metabolic disorder, Interquartile range, Adverse effect, Quartile and Didanosine.
His scientific interests lie mostly in Internal medicine, Immunology, Cohort, Acquired immunodeficiency syndrome and Sida. The various areas that Philippe Morlat examines in his Internal medicine study include Gastroenterology, Surgery and Viral load. Many of his studies on Immunology apply to Risk factor as well.
The concepts of his Cohort study are interwoven with issues in Incidence, Hazard ratio, Confidence interval, Proportional hazards model and Coinfection. He works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to topics relating to Cause of death and, in certain cases, Liver disease, as a part of the same area of interest. His Hepatitis C study integrates concerns from other disciplines, such as Hepatocellular carcinoma and Hepatitis C virus.
His primary scientific interests are in Internal medicine, Cohort, Viral load, Hepatitis C virus and Immunology. Philippe Morlat regularly links together related areas like Gastroenterology in his Internal medicine studies. His Cohort research incorporates elements of Acquired immunodeficiency syndrome, Confidence interval, Proportional hazards model, Coinfection and Cannabis.
His work in Viral load addresses subjects such as Interquartile range, which are connected to disciplines such as Efavirenz, Pharmacogenetics and Single-nucleotide polymorphism. His CD8, Immune system and Interleukin 6 study in the realm of Immunology connects with subjects such as Case management. His research in Sida focuses on subjects like Hepatocellular carcinoma, which are connected to Cause of death and Mortality rate.
His scientific interests lie mostly in Internal medicine, Cohort, Immunology, Cohort study and Randomized controlled trial. The study incorporates disciplines such as Smoking cessation and Reverse-transcriptase inhibitor in addition to Internal medicine. Philippe Morlat has included themes like Cross-sectional study, Physical therapy, Cognitive decline and Confidence interval in his Cohort study.
His Immunology research focuses on CD8 in particular. Philippe Morlat focuses mostly in the field of Cohort study, narrowing it down to matters related to Prospective cohort study and, in some cases, Hazard ratio, Public health, Pregnancy and Pediatrics. His Cause of death research is multidisciplinary, incorporating perspectives in Mortality rate, Malignancy and Epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat.
The Lancet (2014)
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua.
International Journal of Epidemiology (2004)
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
Charlotte Lewden;Geneviève Chene;Philippe Morlat;Francois Raffi.
Journal of Acquired Immune Deficiency Syndromes (2007)
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol
Dominique Salmon-Ceron;Charlotte Lewden;Philippe Morlat;Sibylle Bévilacqua.
Journal of Hepatology (2005)
Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine
B Dannemann;J A McCutchan;D Israelski;D Antoniskis.
Annals of Internal Medicine (1992)
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).
Charlotte Lewden;Thierry May;Eric Rosenthal;Christine Burty.
Journal of Acquired Immune Deficiency Syndromes (2008)
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).
Eric Rosenthal;Marilyne Poirée;Christian Pradier;Christian Perronne.
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Fabrice Bonnet;Fabrice Bonnet;Charlotte Lewden;Thierry May M.D.;Laurence Heripret.
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study
Lene Ryom;Amanda Mocroft;Ole Kirk;Ole Kirk;Signe W Worm.
The Journal of Infectious Diseases (2013)
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave.
Lancet Infectious Diseases (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: